Home > Insider Trading > Filing (0001582945-19-000024)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425627	Transbiotec Inc.	IMLE	Periodicals: Publishing Or Publishing & Printing (2721)	260731818

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1630553	A. Michael Lanphere	400 N. Tustin Ave. Suite 225 Santa Ana CA 92705	V.p. Of Legal Affairs	No	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-28	5,206,430	$0.10	50,144,878	No	4	P	Direct
Common Stock	Acquisiton	2019-08-28	21,400,745	$0.00	71,545,623	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The Reporting Person acquired 5,206,430 shares of the Issuer's common stock in exchange for 520,643 shares of the Issuer's Series A Preferred Stock pursuant to the terms of a Share Exchange Agreement. The exchange was agreed to in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.
The Reporting Person acquired 21,400,745 shares of the Issuer's common stock in exchange for a $96,303.35 reduction in the amount the Issuer owes the Reporting Person under certain promissory notes. The transaction was documented with a Stock Purchase Agreement and was completed in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.